Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
GVBP revoked:
http://www.sec.gov/litigation/admin/2014/34-73337.pdf
What's with all the buys today ?
This stock is dead. A total loss
Trading at 0.001. How do u even place an order for thst price? 10000 shares will cost u $10 + $10 buy comm
Whats the latest on Genova? I bot 10000 shares and got screwed out of 35,000 $$s
Any chance of getting any reimbursement?
This company is still trading ? Newbies out of their minds must be buying this.
Management should be jailed . The name of the company is very deceptive. They want you to think of them as a mini Pfizer, when all they are is a powder fActory run out of mama's basement.
Yup this company is dead . I bought them without doing any dd cos I was flush with cash at the time.
GVBP was proven a 100 percent fraud.
this is the graveyard. where they go to die.
i've held this pos company for 5 years. i try emailing them and the IR person said they haven't heard of them in years! beginning to wonder if this is a fraud. i would luv to sue them and get my $ back.
I am looking hard again at this one, I plan on adding next week the way GVBP has been acting I hate not to have a larger position than what I have only 5000 shares
I have been keeping my eye on this one as well. Last couple of weeks there has been tremendous fluctuation.
Anyone left here, some action here lately or is it just people flipping shares
Highest volume since April...+350,000.
I have been holding also, I have to get .61 to get my money back not counting buy & sell cost
Been some activity lately. Anyone know anything on this stock? I have held on to my shares and hoping for a miracle.
don't know I have been holding this for so long I would have to go into my scottrade account an look it up what I bought at I think it was around $.60 I am scared to look. But its good to here from someone GLTY
wondering how many are holding and if there are any rumors a float
I own about 280,000 Shares, Not too sure I will buy more, I have not heard a peep from these guys. I will continue to hold onto my shares just in case however.
been adding small amounts I first got in @.6932 been trying to average down but like you I had more promising stocks to buy
Not sure, but I was planning to buy some more today but I bought something else instead. If they release news, I will buy from my Zecco Acct, later this week.
GLTU
MB
over 2mil today I wonder whats going on....no news
This stock is starting to trade more and more each day.
good point. GVBP is a good stock to avoid.
I dont underestand every now an then someone buys 500 or so shares in this co. gvbp how do thy expect to get thier money back or make a profit I wrote this dead co off last year. win some lose some I cant belive there is even a board for gvbp
Every now and then, in the great scheme of things there will be these impostors that will take advantage of people like you and I and care not for the damages entailed. Basically, there are bad companies out there and if you happen to run into one, such as GVBP you take your loses; lick your wounds, and live to trade another day. What I'm trying to say is, that there's probably nothing there.
Their address was supposed to be an abandoned building with a note posted on the door. Their industry was originally 'travel' and they were supposedly dealing in pharmaceuticals, which by they way, may have faired well from Oct 08 through April 09, but as an industry is down.
I'm just waiting another 5 months or so, so that I can sell it, and write it off as a loss, come tax season.
Time to invest else ware, my friend.
Waah, waah, waaaahhh.. This stock is still a zero, not a hero.
Genova still has a registered CEO, Mr. Aaron Whiteman. He has just notified the SEC that Genova cannot meet the reporting deadline for the annual accounts. Aaron Whiteman as CEO is liable for what the company does and can be held responsible at any time - whether there are funds or not. For more about Genova you might visit the BLOG on Ventana Biotech. You will see a link between Ventana and Genova and another failed biotech, Nextgen.
You can't sue an entity that essentially doesn't exist....
or that has no money
anyone know of any lawsuits against gvbp? i lost 90% of my portfolio...i really believed in what they were saying...
Ehm...Tim, sometimes it just takes some fireworks and puppet strings and a skeleton will look alive.
Look for example at IRIDQ's multi year candlestick chart since 2000: Pump and Dump with Reloading out of a long time dead company!
lol, well at least your honest! I also knew your intention when you said it, i was trying to say it in a nice way. Some people, no matter how much they have, still need to seek approval of "how good they are", by their peers! So again, Good for you! lol
u mean little to me, as much as any troll...been getting a few hits form this link so i thought i'd rub it in that i nailed this pump & dump...skeletons galore...good day
Tim, how nice it is for you to drop me a line,and remind me of your uncanny insight.I must have made quite an impression to you to remember me after this long with all your 25,000 students!Well, OK yes,you were. It is also sometimes quite possible for one with enough will and fortitude to make a self-fulfilled prophesy if one chooses, of course not to suggest anything like that here.Good to hear from you again!
Greg
turned out dead right didnt i?
anybody got any insight on this stock
- Annual Statement of Changes in Beneficial Ownership (5)
Date : 12/18/2009 @ 3:54PM
Source : Edgar (US Regulatory)
Stock : Genova Biotherapeutics (OTC) (GVBP)
Quote : 0.03 0.0 (0.00%) @ 2:05AM
- Annual Statement of Changes in Beneficial Ownership (5)
FORM 5
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
[ ] Form 3 Holdings Reported
[ X ] Form 4 Transactions Reported UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0362
Expires: February 28, 2011
Estimated average burden
hours per response... 1.0
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
Mardan Consulting Inc.
2. Issuer Name and Ticker or Trading Symbol
Genova Biotherapeutics Inc. [GVBP]
5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director __ X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
1960 - 143 STREET
3. Statement for Issuer's Fiscal Year Ended (MM/DD/YYYY)
12/31/2008
(Street)
SURREY, A1 V4A7Z2
(City) (State) (Zip) 4. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form Filed by One Reporting Person
___ Form Filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4) 7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Amount (A) or (D) Price
Common 6/23/2006 A4 2000000 A $0.05 2000000 D
Common 4/19/2007 S4 1799216 D $0.05 200784 D
Common 12/14/2007 A4 79000 A $0.05 279784 D
Common 8/11/2008 G4 279784 D $0 0 D
Common 3/3/2009 9/16/2008 J4 279784 (1) A $0 279784 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date
(MM/DD/YYYY) 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 8. Price of Derivative Security
(Instr. 5) 9. Number of Derivative Securities Beneficially Owned at End of Issuer's Fiscal Year
(Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4) 11. Nature of Indirect Beneficial Ownership
(Instr. 4)
(A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Warrant $0.05 1/1/2006 A4 2000000 1/1/2006 12/31/2011 Common 2000000 $0.05 0 D
Warrant $0.05 6/23/2006 C4 2000000 1/1/2006 12/31/2011 Common 2000000 $0.05 0 D
Explanation of Responses:
( 1) Shares received as a gift for no consideration
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Mardan Consulting Inc.
1960 - 143 STREET
SURREY, A1 V4A7Z2
X
Signatures
Daniel Baxter, President 12/18/2009
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
- Statement of Changes in Beneficial Ownership (4)
Date : 12/18/2009 @ 4:18PM
Source : Edgar (US Regulatory)
Stock : Genova Biotherapeutics (OTC) (GVBP)
Quote : 0.03 0.0 (0.00%) @ 2:05AM
- Statement of Changes in Beneficial Ownership (4)
FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
1. Name and Address of Reporting Person *
Mardan Consulting Inc. 2. Issuer Name and Ticker or Trading Symbol
Genova Biotherapeutics Inc. [ GVBP ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable)
_____ Director __ X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
1960 - 143 STREET 3. Date of Earliest Transaction (MM/DD/YYYY)
7/13/2009
(Street)
SURREY, A1 V4A7Z2
(City) (State) (Zip) 4. If Amendment, Date Original Filed (MM/DD/YYYY)
6. Individual or Joint/Group Filing (Check Applicable Line)
_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common 7/13/2009 J (1) 34393216 A $0 34973000 D
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 8. Price of Derivative Security
(Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
( 1) Additional shares received as a result of the 125-for-1 forward stock split effective July 13/09
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
Mardan Consulting Inc.
1960 - 143 STREET
SURREY, A1 V4A7Z2
X
Signatures
Daniel Baxter, President 12/18/2009
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
GENova Biotherapeutics (GVBP) SqueezeTrigger Price is $0.43. Approximately 57 Million Shares Shorted Since July 2009 Accordin...
Date : 09/17/2009 @ 1:40AM
Source : Business Wire
Stock : BUYINS.NET (GVBP)
Quote : 0.03 0.005 (20.00%) @ 8:50AM
GENova Biotherapeutics (GVBP) SqueezeTrigger Price is $0.43. Approximately 57 Million Shares Shorted Since July 2009 Accordin...
GENova Biotherapeutics Inc. ("GENova")(OTCBB: GVBP.OB), a biotechnology company that develops novel therapeutic proteins that disrupt the advance of life-threatening cancers, today announced BUYINS.NET, www.buyins.net, is initiating coverage of GENova Biotherapeutics after releasing the latest short sale data to September 2009. From July 2009 to September 2009 approximately 382 million total aggregate shares of GVBP have traded for a total dollar value of approximately $166 million. The total aggregate number of shares shorted in this time period is approximately 57 million shares. The GVBP SqueezeTrigger price of $0.43 is the volume weighted average short price of all short selling in GVBP. A series of short squeezes has begun as shares of GVBP have jumped from $0.06 to a high of $1.18 and 62% of all shares shorted in GVBP are now out-of-the-money. To access SqueezeTrigger Prices ahead of potential short squeezes beginning, visit http://www.buyins.net
Day Total Vol. Short Vol. Avg. Price Short $ Value 7/10/2009 168,750 25,313 $0.0640 $1,620 7/14/2009 4,000 600 $0.2500 $150 7/15/2009 26,000 3,900 $0.2500 $975 7/16/2009 5,000 750 $0.2000 $150 7/17/2009 5,000 750 $0.1500 $113 7/20/2009 5,000 750 $0.1200 $90 7/22/2009 11,250 1,688 $0.0700 $118 7/23/2009 5,000 750 $0.0500 $38 7/27/2009 50,000 7,500 $0.0475 $356 7/28/2009 5,000 750 $0.0400 $30 7/30/2009 15,000 2,250 $0.0350 $79 7/31/2009 20,000 3,000 $0.0300 $90 8/4/2009 5,000 750 $0.0400 $30 8/6/2009 5,000 750 $0.0600 $45 8/11/2009 10,000 1,500 $0.0500 $75 8/12/2009 17,500 2,625 $0.0350 $92 8/13/2009 210,000 31,500 $0.0425 $1,339 8/19/2009 283,100 42,465 $0.0575 $2,442 8/20/2009 166,500 24,975 $0.0388 $969 8/21/2009 420,500 63,075 $0.0350 $2,208 8/24/2009 843,750 126,563 $0.0390 $4,936 8/25/2009 517,500 77,625 $0.0582 $4,518 8/26/2009 1,134,000 170,100 $0.0583 $9,917 8/27/2009 138,709 20,806 $0.0702 $1,461 8/28/2009 299,600 44,940 $0.0800 $3,595 8/31/2009 248,000 37,200 $0.0850 $3,162 9/1/2009 110,000 16,500 $0.0890 $1,469 9/2/2009 258,000 38,700 $0.0887 $3,433 9/3/2009 105,400 15,810 $0.0890 $1,407 9/4/2009 4,343,805 651,571 $0.1145 $74,605 9/8/2009 31,013,712 4,652,057 $0.1495 $695,482 9/9/2009 39,063,840 5,859,576 $0.1798 $1,053,552 9/10/2009 22,838,746 3,425,812 $0.2092 $716,680 9/11/2009 73,966,584 11,094,988 $0.2833 $3,143,210 9/14/2009 61,006,116 9,150,917 $0.3797 $3,474,603 9/15/2009 58,753,648 8,813,047 $0.6638 $5,850,101 9/16/2009 86,543,080 12,981,462 $0.7663 $9,947,694 TOTAL 382,622,090 57,393,314 $0.4356 $25,000,831 *short volume is approximated using a proprietary algorithm
**average short price is calculated using a volume weighted average short price
***short volume is the total short trade volume and does not account for covers
Click here to view chart: http://www.buyins.com/images/gvbpstr9-16-09.jpg Market Maker Friction Factor is shown in the chart below: Date BuyVol SellVol Volume NetVol Change Friction Factor 9/16/2009 32,528,297 33,050,882 86,530,981 -522,585 -$0.2400 -21,774 9/15/2009 29,732,263 27,395,775 58,753,648 2,336,488 $0.3650 64,013 9/14/2009 29,906,751 24,121,644 61,006,116 5,785,107 $0.1400 413,222 9/11/2009 36,565,346 34,967,902 73,966,584 1,597,444 $0.0670 238,424 9/10/2009 12,536,576 9,450,995 22,838,746 3,085,581 $0.0380 811,995 9/9/2009 20,201,469 17,231,916 39,063,840 2,969,553 $0.0280 1,060,555 9/8/2009 15,917,091 12,883,521 31,013,712 3,033,570 $0.0370 819,884 9/4/2009 2,278,871 1,814,934 4,343,805 463,937 $0.0300 154,646 9/3/2009 71,500 33,900 105,400 37,600 $0.0000 bearish bias 9/2/2009 253,000 5,000 258,000 248,000 $0.0000 bearish bias 9/1/2009 60,000 50,000 110,000 10,000 $0.0000 bearish bias 8/31/2009 148,000 0 248,000 148,000 $0.0100 148,000 8/28/2009 299,600 0 299,600 299,600 $0.0080 374,500 8/27/2009 105,000 33,709 138,709 71,291 $0.0070 101,844 8/26/2009 628,000 434,000 1,134,000 194,000 $0.0230 84,348 8/25/2009 628,000 434,000 517,500 194,000 $0.0060 323,333 8/24/2009 593,750 235,000 843,750 358,750 $0.0060 597,917 8/21/2009 235,500 185,000 420,500 50,500 -$0.0100 bearish bias 8/20/2009 86,500 80,000 166,500 6,500 $0.0100 6,500 8/19/2009 128,100 130,000 283,100 -1,900 $0.0000 bullish bias 8/13/2009 100,000 110,000 210,000 -10,000 $0.0000 bullish bias 8/12/2009 0 17,500 17,500 -17,500 -$0.0100 -17,500 8/11/2009 5,000 5,000 10,000 0 -$0.0200 bearish bias 8/6/2009 5,000 0 5,000 5,000 $0.0200 2,500 Click here to view chart: http://www.buyins.com/images/gvbpff9-16-09.jpg Analysis of the Friction Factor chart above shows that in the trading days preceding this report that market makers have been making a positively biased market (70% bullish and 30% bearish bias to trading) in shares of GVBP. The Friction Factor displays how many more shares of buying than selling are required to move GVBP higher by one cent or how many more shares of selling than buying moves GVBP lower by 1 cent
The chart below shows the broker dealers acting as market makers in shares of GVBP through August 2009
Rank Market Maker Volume thru August Percent of Volume 1 Knight Equity Markets, L.P
1,211,059 27% 2 Hudson Securities, Inc
1,200,750 27% 3 Noble International Invest
782,500 17% 4 Sterne, Agee & Leach, Inc
688,000 15% 5 Domestic Securities, Inc
238,100 5% 6 Automated Trading Desk 180,000 4% 7 R. F. Lafferty & Co., Inc
25,000
Hi Board, anything new with this scam company?
Well I took the plunge with OZON, since my gut feeling is this is where BioGenovia is placing their buisness and this will turn into a dead shell.
Not bashing this, and been out for months with selling all my free shares for peanuts so have no gridge. I think the MM games killed this issue and OZON is BG way of distancing them selves.
May be a big mistake on my part but just got in 200K strong.
If yall are in this still looking for a heart beat, check out OZON.
A post on two different boards have this raging bull post of where BioGenovia owns their domain name.
Could be the rebirth and round two for old GVBP
Good luck with this one.
At least your at the end of the year and can take the tax loss on your winnings this year. No reason to be owning this anymore.
PS I use scottrade and its still on the do not buy list. Thank God is not on the other Do not buy or sell list.
It all has to do with the DTCC and clearing of shares. Probably MM sellinbg shares that wern't even real and couldn't clear those shares in the 3 days resulting in everyone getting screwed.
Iwas able to dump after the two week halt, so it wasn't a total fraud.
Maybe they do have something real and now packaging it under a different symbol.
Sort of funny finding that today
GLTA
here ya go
http://ragingbull.quote.com/mboard/boards.cgi?board=OZON&read=11053
There is no bid/ask for stocks trading in the grey market. Be very careful, this stock is a full blown scam.
Followers
|
16
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1341
|
Created
|
07/12/09
|
Type
|
Free
|
Moderators |
Genova Biotherapeutics, Inc. (GVBP)
Company Information:
1461 A. First Ave. #360
New York, NY 10021-2209
Phone: 646-845-1920
Fax: 646-514-7436
E-mail: investorrelations@genovabio.com
CIK: 0001364587
GENova is a biotechnological drug development company with a strict focus on identifying, evaluating and acquiring new promising drugs for treatment and prevention of oncological and infectious diseases in human beings.
Each and every product candidate targets problem areas with considerable unmet need and ditto market potential. Subsequent inexpensive value-addition benefits both patients and stakeholders.
Fully developed our efficient programmes are then transferred to larger organizations, these being either other biotech companies and/or Big Pharma with infrastructures large enough to bring the products to market in a big scale.
Management:
http://www.genovabio.com/management.html
GENova is fully committed to ensuring that the company can continue to operate and bring both new and exciting partners into the business and pursue the capital opportunities that the company was closing prior to the SEC investigation. Subsequently we are re-organizing the management team and corporate structure to better reflect legal, market and capital requirements.
GENOVA MANAGEMENT
NOTE TO SHAREHOLDERS!!!
Recent News: http://www.otcmarkets.com/pink/quote/quote.jsp?symbol=gvbp
OTC Disclosure & News Service | |||||||||
|
Filings:
Transfer Agent:
Action Stock Transfer
7069 Highland Drive
Suite 300
Salt Lake City, UT 84121
Share Structure:
coming
Investor Relations:
Windfall Communications LLC.
Brian Cook
Tel: +1 (866)797-8703
info@windfallcommunications.com
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Rules of the board according to IHUB:
http://www.investorshub.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |